COVID-19 Impact on Global Non-Opioid Pain Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 91 pages | ID: CCC77FFCEBCFEN
QYResearch

Abstracts

This report focuses on the global Non-Opioid Pain Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-Opioid Pain Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Allergan PLC
• Canopy Growth
• Medical Marijuana Inc.
• Panag Pharma Inc.
• Tilray
• Aphria Inc.
• Bedrocan
• Cara Therapeutics
• Centrexion Therapeutics
• CHT Medical
• Cronos Group
• GW Pharmaceuticals
• Medropharm Gmbh
• US Worldmeds LLC

Market segment by Type, the product can be split into

• Medical Cannabis Treatment
• Capsaicin-derived Treatment
• Menthol-containing Treatment
• Omega 3 fatty acid-containing Treatment
• Botulinum Toxins

Market segment by Application, split into

• Orthopaedic and Musculoskeletal Pain
• Neuropathic Pain
• Cancer Pain
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Non-Opioid Pain Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Non-Opioid Pain Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Non-Opioid Pain Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Non-Opioid Pain Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Non-Opioid Pain Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Medical Cannabis Treatment
  1.4.3 Capsaicin-derived Treatment
  1.4.4 Menthol-containing Treatment
  1.4.5 Omega 3 fatty acid-containing Treatment
  1.4.6 Botulinum Toxins
1.5 Market by Application
  1.5.1 Global Non-Opioid Pain Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Orthopaedic and Musculoskeletal Pain
  1.5.3 Neuropathic Pain
  1.5.4 Cancer Pain
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Non-Opioid Pain Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Non-Opioid Pain Treatment Industry
    1.6.1.1 Non-Opioid Pain Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Non-Opioid Pain Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Non-Opioid Pain Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Non-Opioid Pain Treatment Market Perspective (2015-2026)
2.2 Non-Opioid Pain Treatment Growth Trends by Regions
  2.2.1 Non-Opioid Pain Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Non-Opioid Pain Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Non-Opioid Pain Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Non-Opioid Pain Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Non-Opioid Pain Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Non-Opioid Pain Treatment Players by Market Size
  3.1.1 Global Top Non-Opioid Pain Treatment Players by Revenue (2015-2020)
  3.1.2 Global Non-Opioid Pain Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Non-Opioid Pain Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Non-Opioid Pain Treatment Market Concentration Ratio
  3.2.1 Global Non-Opioid Pain Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Non-Opioid Pain Treatment Revenue in 2019
3.3 Non-Opioid Pain Treatment Key Players Head office and Area Served
3.4 Key Players Non-Opioid Pain Treatment Product Solution and Service
3.5 Date of Enter into Non-Opioid Pain Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Non-Opioid Pain Treatment Historic Market Size by Type (2015-2020)
4.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2021-2026)

5 NON-OPIOID PAIN TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Non-Opioid Pain Treatment Market Size by Application (2015-2020)
5.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Non-Opioid Pain Treatment Market Size (2015-2020)
6.2 Non-Opioid Pain Treatment Key Players in North America (2019-2020)
6.3 North America Non-Opioid Pain Treatment Market Size by Type (2015-2020)
6.4 North America Non-Opioid Pain Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Non-Opioid Pain Treatment Market Size (2015-2020)
7.2 Non-Opioid Pain Treatment Key Players in Europe (2019-2020)
7.3 Europe Non-Opioid Pain Treatment Market Size by Type (2015-2020)
7.4 Europe Non-Opioid Pain Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Non-Opioid Pain Treatment Market Size (2015-2020)
8.2 Non-Opioid Pain Treatment Key Players in China (2019-2020)
8.3 China Non-Opioid Pain Treatment Market Size by Type (2015-2020)
8.4 China Non-Opioid Pain Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Non-Opioid Pain Treatment Market Size (2015-2020)
9.2 Non-Opioid Pain Treatment Key Players in Japan (2019-2020)
9.3 Japan Non-Opioid Pain Treatment Market Size by Type (2015-2020)
9.4 Japan Non-Opioid Pain Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Non-Opioid Pain Treatment Market Size (2015-2020)
10.2 Non-Opioid Pain Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Non-Opioid Pain Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Non-Opioid Pain Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Non-Opioid Pain Treatment Market Size (2015-2020)
11.2 Non-Opioid Pain Treatment Key Players in India (2019-2020)
11.3 India Non-Opioid Pain Treatment Market Size by Type (2015-2020)
11.4 India Non-Opioid Pain Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Non-Opioid Pain Treatment Market Size (2015-2020)
12.2 Non-Opioid Pain Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Non-Opioid Pain Treatment Market Size by Type (2015-2020)
12.4 Central & South America Non-Opioid Pain Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Allergan PLC
  13.1.1 Allergan PLC Company Details
  13.1.2 Allergan PLC Business Overview and Its Total Revenue
  13.1.3 Allergan PLC Non-Opioid Pain Treatment Introduction
  13.1.4 Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2015-2020))
  13.1.5 Allergan PLC Recent Development
13.2 Canopy Growth
  13.2.1 Canopy Growth Company Details
  13.2.2 Canopy Growth Business Overview and Its Total Revenue
  13.2.3 Canopy Growth Non-Opioid Pain Treatment Introduction
  13.2.4 Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  13.2.5 Canopy Growth Recent Development
13.3 Medical Marijuana Inc.
  13.3.1 Medical Marijuana Inc. Company Details
  13.3.2 Medical Marijuana Inc. Business Overview and Its Total Revenue
  13.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Introduction
  13.3.4 Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  13.3.5 Medical Marijuana Inc. Recent Development
13.4 Panag Pharma Inc.
  13.4.1 Panag Pharma Inc. Company Details
  13.4.2 Panag Pharma Inc. Business Overview and Its Total Revenue
  13.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Introduction
  13.4.4 Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  13.4.5 Panag Pharma Inc. Recent Development
13.5 Tilray
  13.5.1 Tilray Company Details
  13.5.2 Tilray Business Overview and Its Total Revenue
  13.5.3 Tilray Non-Opioid Pain Treatment Introduction
  13.5.4 Tilray Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  13.5.5 Tilray Recent Development
13.6 Aphria Inc.
  13.6.1 Aphria Inc. Company Details
  13.6.2 Aphria Inc. Business Overview and Its Total Revenue
  13.6.3 Aphria Inc. Non-Opioid Pain Treatment Introduction
  13.6.4 Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  13.6.5 Aphria Inc. Recent Development
13.7 Bedrocan
  13.7.1 Bedrocan Company Details
  13.7.2 Bedrocan Business Overview and Its Total Revenue
  13.7.3 Bedrocan Non-Opioid Pain Treatment Introduction
  13.7.4 Bedrocan Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  13.7.5 Bedrocan Recent Development
13.8 Cara Therapeutics
  13.8.1 Cara Therapeutics Company Details
  13.8.2 Cara Therapeutics Business Overview and Its Total Revenue
  13.8.3 Cara Therapeutics Non-Opioid Pain Treatment Introduction
  13.8.4 Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  13.8.5 Cara Therapeutics Recent Development
13.9 Centrexion Therapeutics
  13.9.1 Centrexion Therapeutics Company Details
  13.9.2 Centrexion Therapeutics Business Overview and Its Total Revenue
  13.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Introduction
  13.9.4 Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  13.9.5 Centrexion Therapeutics Recent Development
13.10 CHT Medical
  13.10.1 CHT Medical Company Details
  13.10.2 CHT Medical Business Overview and Its Total Revenue
  13.10.3 CHT Medical Non-Opioid Pain Treatment Introduction
  13.10.4 CHT Medical Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  13.10.5 CHT Medical Recent Development
13.11 Cronos Group
  10.11.1 Cronos Group Company Details
  10.11.2 Cronos Group Business Overview and Its Total Revenue
  10.11.3 Cronos Group Non-Opioid Pain Treatment Introduction
  10.11.4 Cronos Group Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  10.11.5 Cronos Group Recent Development
13.12 GW Pharmaceuticals
  10.12.1 GW Pharmaceuticals Company Details
  10.12.2 GW Pharmaceuticals Business Overview and Its Total Revenue
  10.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Introduction
  10.12.4 GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  10.12.5 GW Pharmaceuticals Recent Development
13.13 Medropharm Gmbh
  10.13.1 Medropharm Gmbh Company Details
  10.13.2 Medropharm Gmbh Business Overview and Its Total Revenue
  10.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Introduction
  10.13.4 Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  10.13.5 Medropharm Gmbh Recent Development
13.14 US Worldmeds LLC
  10.14.1 US Worldmeds LLC Company Details
  10.14.2 US Worldmeds LLC Business Overview and Its Total Revenue
  10.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Introduction
  10.14.4 US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2015-2020)
  10.14.5 US Worldmeds LLC Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Non-Opioid Pain Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Non-Opioid Pain Treatment Revenue
Table 3. Ranking of Global Top Non-Opioid Pain Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Non-Opioid Pain Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medical Cannabis Treatment
Table 6. Key Players of Capsaicin-derived Treatment
Table 7. Key Players of Menthol-containing Treatment
Table 8. Key Players of Omega 3 fatty acid-containing Treatment
Table 9. Key Players of Botulinum Toxins
Table 10. COVID-19 Impact Global Market: (Four Non-Opioid Pain Treatment Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Non-Opioid Pain Treatment Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Non-Opioid Pain Treatment Players to Combat Covid-19 Impact
Table 15. Global Non-Opioid Pain Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Non-Opioid Pain Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Non-Opioid Pain Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Non-Opioid Pain Treatment Market Share by Regions (2015-2020)
Table 19. Global Non-Opioid Pain Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Non-Opioid Pain Treatment Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Non-Opioid Pain Treatment Market Growth Strategy
Table 25. Main Points Interviewed from Key Non-Opioid Pain Treatment Players
Table 26. Global Non-Opioid Pain Treatment Revenue by Players (2015-2020) (Million US$)
Table 27. Global Non-Opioid Pain Treatment Market Share by Players (2015-2020)
Table 28. Global Top Non-Opioid Pain Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Opioid Pain Treatment as of 2019)
Table 29. Global Non-Opioid Pain Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Non-Opioid Pain Treatment Product Solution and Service
Table 32. Date of Enter into Non-Opioid Pain Treatment Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Non-Opioid Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. Global Non-Opioid Pain Treatment Market Size Share by Type (2015-2020)
Table 36. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2021-2026)
Table 37. Global Non-Opioid Pain Treatment Market Size Share by Application (2015-2020)
Table 38. Global Non-Opioid Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. Global Non-Opioid Pain Treatment Market Size Share by Application (2021-2026)
Table 40. North America Key Players Non-Opioid Pain Treatment Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Non-Opioid Pain Treatment Market Share (2019-2020)
Table 42. North America Non-Opioid Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. North America Non-Opioid Pain Treatment Market Share by Type (2015-2020)
Table 44. North America Non-Opioid Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. North America Non-Opioid Pain Treatment Market Share by Application (2015-2020)
Table 46. Europe Key Players Non-Opioid Pain Treatment Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Non-Opioid Pain Treatment Market Share (2019-2020)
Table 48. Europe Non-Opioid Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Non-Opioid Pain Treatment Market Share by Type (2015-2020)
Table 50. Europe Non-Opioid Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Non-Opioid Pain Treatment Market Share by Application (2015-2020)
Table 52. China Key Players Non-Opioid Pain Treatment Revenue (2019-2020) (Million US$)
Table 53. China Key Players Non-Opioid Pain Treatment Market Share (2019-2020)
Table 54. China Non-Opioid Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. China Non-Opioid Pain Treatment Market Share by Type (2015-2020)
Table 56. China Non-Opioid Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. China Non-Opioid Pain Treatment Market Share by Application (2015-2020)
Table 58. Japan Key Players Non-Opioid Pain Treatment Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Non-Opioid Pain Treatment Market Share (2019-2020)
Table 60. Japan Non-Opioid Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Non-Opioid Pain Treatment Market Share by Type (2015-2020)
Table 62. Japan Non-Opioid Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Non-Opioid Pain Treatment Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Non-Opioid Pain Treatment Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Non-Opioid Pain Treatment Market Share (2019-2020)
Table 66. Southeast Asia Non-Opioid Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Non-Opioid Pain Treatment Market Share by Type (2015-2020)
Table 68. Southeast Asia Non-Opioid Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Non-Opioid Pain Treatment Market Share by Application (2015-2020)
Table 70. India Key Players Non-Opioid Pain Treatment Revenue (2019-2020) (Million US$)
Table 71. India Key Players Non-Opioid Pain Treatment Market Share (2019-2020)
Table 72. India Non-Opioid Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. India Non-Opioid Pain Treatment Market Share by Type (2015-2020)
Table 74. India Non-Opioid Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. India Non-Opioid Pain Treatment Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Non-Opioid Pain Treatment Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Non-Opioid Pain Treatment Market Share (2019-2020)
Table 78. Central & South America Non-Opioid Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Non-Opioid Pain Treatment Market Share by Type (2015-2020)
Table 80. Central & South America Non-Opioid Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Non-Opioid Pain Treatment Market Share by Application (2015-2020)
Table 82. Allergan PLC Company Details
Table 83. Allergan PLC Business Overview
Table 84. Allergan PLC Product
Table 85. Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2015-2020) (Million US$)
Table 86. Allergan PLC Recent Development
Table 87. Canopy Growth Company Details
Table 88. Canopy Growth Business Overview
Table 89. Canopy Growth Product
Table 90. Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2015-2020) (Million US$)
Table 91. Canopy Growth Recent Development
Table 92. Medical Marijuana Inc. Company Details
Table 93. Medical Marijuana Inc. Business Overview
Table 94. Medical Marijuana Inc. Product
Table 95. Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2015-2020) (Million US$)
Table 96. Medical Marijuana Inc. Recent Development
Table 97. Panag Pharma Inc. Company Details
Table 98. Panag Pharma Inc. Business Overview
Table 99. Panag Pharma Inc. Product
Table 100. Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2015-2020) (Million US$)
Table 101. Panag Pharma Inc. Recent Development
Table 102. Tilray Company Details
Table 103. Tilray Business Overview
Table 104. Tilray Product
Table 105. Tilray Revenue in Non-Opioid Pain Treatment Business (2015-2020) (Million US$)
Table 106. Tilray Recent Development
Table 107. Aphria Inc. Company Details
Table 108. Aphria Inc. Business Overview
Table 109. Aphria Inc. Product
Table 110. Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2015-2020) (Million US$)
Table 111. Aphria Inc. Recent Development
Table 112. Bedrocan Company Details
Table 113. Bedrocan Business Overview
Table 114. Bedrocan Product
Table 115. Bedrocan Revenue in Non-Opioid Pain Treatment Business (2015-2020) (Million US$)
Table 116. Bedrocan Recent Development
Table 117. Cara Therapeutics Business Overview
Table 118. Cara Therapeutics Product
Table 119. Cara Therapeutics Company Details
Table 120. Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2015-2020) (Million US$)
Table 121. Cara Therapeutics Recent Development
Table 122. Centrexion Therapeutics Company Details
Table 123. Centrexion Therapeutics Business Overview
Table 124. Centrexion Therapeutics Product
Table 125. Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2015-2020) (Million US$)
Table 126. Centrexion Therapeutics Recent Development
Table 127. CHT Medical Company Details
Table 128. CHT Medical Business Overview
Table 129. CHT Medical Product
Table 130. CHT Medical Revenue in Non-Opioid Pain Treatment Business (2015-2020) (Million US$)
Table 131. CHT Medical Recent Development
Table 132. Cronos Group Company Details
Table 133. Cronos Group Business Overview
Table 134. Cronos Group Product
Table 135. Cronos Group Revenue in Non-Opioid Pain Treatment Business (2015-2020) (Million US$)
Table 136. Cronos Group Recent Development
Table 137. GW Pharmaceuticals Company Details
Table 138. GW Pharmaceuticals Business Overview
Table 139. GW Pharmaceuticals Product
Table 140. GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2015-2020) (Million US$)
Table 141. GW Pharmaceuticals Recent Development
Table 142. Medropharm Gmbh Company Details
Table 143. Medropharm Gmbh Business Overview
Table 144. Medropharm Gmbh Product
Table 145. Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2015-2020) (Million US$)
Table 146. Medropharm Gmbh Recent Development
Table 147. US Worldmeds LLC Company Details
Table 148. US Worldmeds LLC Business Overview
Table 149. US Worldmeds LLC Product
Table 150. US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2015-2020) (Million US$)
Table 151. US Worldmeds LLC Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Non-Opioid Pain Treatment Market Share by Type: 2020 VS 2026
Figure 2. Medical Cannabis Treatment Features
Figure 3. Capsaicin-derived Treatment Features
Figure 4. Menthol-containing Treatment Features
Figure 5. Omega 3 fatty acid-containing Treatment Features
Figure 6. Botulinum Toxins Features
Figure 7. Global Non-Opioid Pain Treatment Market Share by Application: 2020 VS 2026
Figure 8. Orthopaedic and Musculoskeletal Pain Case Studies
Figure 9. Neuropathic Pain Case Studies
Figure 10. Cancer Pain Case Studies
Figure 11. Others Case Studies
Figure 12. Non-Opioid Pain Treatment Report Years Considered
Figure 13. Global Non-Opioid Pain Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Non-Opioid Pain Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Non-Opioid Pain Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Non-Opioid Pain Treatment Market Share by Players in 2019
Figure 18. Global Top Non-Opioid Pain Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Opioid Pain Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Non-Opioid Pain Treatment Revenue in 2019
Figure 20. North America Non-Opioid Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Non-Opioid Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Non-Opioid Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Non-Opioid Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Non-Opioid Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Non-Opioid Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Non-Opioid Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Allergan PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Allergan PLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2015-2020)
Figure 29. Canopy Growth Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Canopy Growth Revenue Growth Rate in Non-Opioid Pain Treatment Business (2015-2020)
Figure 31. Medical Marijuana Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Medical Marijuana Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2015-2020)
Figure 33. Panag Pharma Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Panag Pharma Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2015-2020)
Figure 35. Tilray Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Tilray Revenue Growth Rate in Non-Opioid Pain Treatment Business (2015-2020)
Figure 37. Aphria Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Aphria Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2015-2020)
Figure 39. Bedrocan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Bedrocan Revenue Growth Rate in Non-Opioid Pain Treatment Business (2015-2020)
Figure 41. Cara Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Cara Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2015-2020)
Figure 43. Centrexion Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Centrexion Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2015-2020)
Figure 45. CHT Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. CHT Medical Revenue Growth Rate in Non-Opioid Pain Treatment Business (2015-2020)
Figure 47. Cronos Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Cronos Group Revenue Growth Rate in Non-Opioid Pain Treatment Business (2015-2020)
Figure 49. GW Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. GW Pharmaceuticals Revenue Growth Rate in Non-Opioid Pain Treatment Business (2015-2020)
Figure 51. Medropharm Gmbh Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Medropharm Gmbh Revenue Growth Rate in Non-Opioid Pain Treatment Business (2015-2020)
Figure 53. US Worldmeds LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. US Worldmeds LLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed